207 related articles for article (PubMed ID: 32898690)
21. Construction and verification of prognostic nomogram for early-onset esophageal cancer.
Liu X; Guo W; Shi X; Ke Y; Li Y; Pan S; Jin Y; Wang Y; Ruan Q; Ma H
Bosn J Basic Med Sci; 2021 Dec; 21(6):760-772. PubMed ID: 33823125
[TBL] [Abstract][Full Text] [Related]
22. Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study.
Liu Y; Sun M; Xiong Y; Gu X; Zhang K; Liu L
Technol Cancer Res Treat; 2022; 21():15330338221132035. PubMed ID: 36217877
[No Abstract] [Full Text] [Related]
23. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study.
Xiao Y; Peng S; Hu Y; Zhang J; Cao X
Cancer Med; 2020 Nov; 9(22):8562-8570. PubMed ID: 32941704
[TBL] [Abstract][Full Text] [Related]
26. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
27. Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.
Liu A; Zhang G; Yang Y; Xia Y; Li W; Liu Y; Cui Q; Wang D; Yu J
Cancer Immunol Immunother; 2024 Jun; 73(8):152. PubMed ID: 38833153
[TBL] [Abstract][Full Text] [Related]
28. Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis.
Guo M; Li B; Yu Y; Wang S; Xu Y; Sun X; Wang L; Yu J
Cancer Med; 2019 May; 8(5):2587-2598. PubMed ID: 30945441
[TBL] [Abstract][Full Text] [Related]
29. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a Prognostic Nomogram for Lung Adenocarcinoma with Brain Metastases.
Huang Z; Tong Y; Tian H; Zhao C
World Neurosurg; 2020 Sep; 141():e700-e709. PubMed ID: 32531436
[TBL] [Abstract][Full Text] [Related]
31. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
[TBL] [Abstract][Full Text] [Related]
32. A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC).
Wu Z; Ouyang C; Peng L
Med Sci Monit; 2020 Jun; 26():e923231. PubMed ID: 32479428
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a nomogram to predict synchronous lung metastases in patients with ovarian cancer: a large cohort study.
Yuan Y; Guo F; Wang R; Zhang Y; Bai G
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33175143
[TBL] [Abstract][Full Text] [Related]
34. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
Zeng Y; Mayne N; Yang CJ; D'Amico TA; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; Liu Y; Huang W; He J; Wang W; Jiang L; Cui F; Wang W; Liang W; He J;
Ann Surg Oncol; 2019 Jul; 26(7):2053-2062. PubMed ID: 30900105
[TBL] [Abstract][Full Text] [Related]
35. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
[TBL] [Abstract][Full Text] [Related]
36. A nomogram for predicting overall survival rate in patients with brain metastatic non-small cell lung cancer.
Peng S; Xiao Y; Li X; Wu Z
Medicine (Baltimore); 2022 Sep; 101(38):e30824. PubMed ID: 36197226
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
38. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
39. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]